Wecare Probiotics Co., Ltd., established in 2013 and based in the Wujiang Economic and Technological Development Zone of Suzhou, Jiangsu, manufactures probiotic active pharmaceutical ingredients and bio products under its WecLac brand, including Lactobacillus plantarum, Lactobacillus acidophilus, Bifidobacterium longum and animalis subspecies, and rhamnosus strains. Exporting about 60% of its output, the company offers CRO, CMO, and CDMO contract manufacturing under OEM, ODM, and own-brand arrangements, counts Bayer among its customers, and sells across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
Aucun commentaire disponible.
Laissez votre note & commentaire